<?xml version="1.0" encoding="UTF-8"?>
<bibdataset xsi:schemaLocation="http://www.elsevier.com/xml/ani/ani http://www.elsevier.com/xml/ani/ani512.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns="http://www.elsevier.com/xml/ani/ani">
<item>
<ait:process-info>
<ait:date-delivered year="2016" month="06" day="15"/>
<ait:date-sort year="2015" month="01" day="01"/>
<ait:status type="core" state="new" stage="S300"/>
</ait:process-info>
<bibrecord>
<item-info>
<copyright type="Elsevier">Copyright 2016 Elsevier B.V., All rights reserved.</copyright>
<itemidlist>
<ce:doi>10.3233/978-1-61499-564-7-975</ce:doi>
<itemid idtype="PUI">23103563</itemid>
<itemid idtype="CAR-ID">643592588</itemid>
<itemid idtype="NURSNG">2016002332</itemid>
<itemid idtype="SNEMB">2016001390</itemid>
</itemidlist>
<history>
<date-created timestamp="BST 05:16:11" year="2016" month="01" day="04"/>
</history>
<dbcollection>NURSNG</dbcollection>
<dbcollection>SNEMB</dbcollection>
</item-info>
<head>
<citation-info>
<citation-type code="cp"/>
<citation-language xml:lang="eng"/>
<abstract-language xml:lang="eng"/>
<author-keywords>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
</author-keywords>
</citation-info>
<citation-title>
<titletext xml:lang="eng" original="y">the</titletext>
</citation-title>
<author-group>
<author seq="1" type="auth">
<ce:initials>M.</ce:initials>
<ce:indexed-name>Nishikitani M.</ce:indexed-name>
<ce:surname>Nishikitani</ce:surname>
<ce:given-name>Mariko</ce:given-name>
<ce:e-address>makorin@med.kyushu-u.ac.jp</ce:e-address>
</author>
<author seq="5" type="auth">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Ahmed A.</ce:indexed-name>
<ce:surname>Ahmed</ce:surname>
<ce:given-name>Ashir</ce:given-name>
</author>
<author seq="6" type="auth">
<ce:initials>N.</ce:initials>
<ce:indexed-name>Nakashima N.</ce:indexed-name>
<ce:surname>Nakashima</ce:surname>
<ce:given-name>Naoki</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Institute of Decision Science for A Sustainable Society</organization>
<organization>Kyushu University</organization>
<address-part>3-1-1 Maidashi</address-part>
<city>Fukuoka</city>
<postal-code>812-8582</postal-code>
</affiliation>
</author-group>
<author-group>
<author seq="2" type="auth">
<ce:initials>Y.</ce:initials>
<ce:indexed-name>Nohara Y.</ce:indexed-name>
<ce:surname>Nohara</ce:surname>
<ce:given-name>Yasunobu</ce:given-name>
</author>
<author seq="6" type="auth">
<ce:initials>N.</ce:initials>
<ce:indexed-name>Nakashima N.</ce:indexed-name>
<ce:surname>Nakashima</ce:surname>
<ce:given-name>Naoki</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Medical Information Center</organization>
<organization>Kyushu University Hospital</organization>
<city>Fukuoka</city>
</affiliation>
</author-group>
<author-group>
<author seq="3" type="auth">
<ce:initials>P.</ce:initials>
<ce:indexed-name>Ghosh P.</ce:indexed-name>
<ce:surname>Ghosh</ce:surname>
<ce:given-name>Partha</ce:given-name>
</author>
<author seq="4" type="auth">
<ce:initials>R.</ce:initials>
<ce:indexed-name>Islam Maruf R.</ce:indexed-name>
<ce:surname>Islam Maruf</ce:surname>
<ce:given-name>Rafiqul</ce:given-name>
</author>
<affiliation country="bgd">
<organization>Grameen Communications</organization>
<city>Dhaka</city>
</affiliation>
</author-group>
<author-group>
<author seq="5" type="auth">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Ahmed A.</ce:indexed-name>
<ce:surname>Ahmed</ce:surname>
<ce:given-name>Ashir</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Graduate School of Information Science and Electrical Engineering</organization>
<organization>Kyushu University</organization>
<city>Fukuoka</city>
</affiliation>
</author-group>
<correspondence>
<person>
<ce:initials>M.</ce:initials>
<ce:indexed-name>Nishikitani M.</ce:indexed-name>
<ce:surname>Nishikitani</ce:surname>
<ce:given-name>Mariko</ce:given-name>
</person>
<affiliation country="jpn">
<organization>Institute of Decision Science for A Sustainable Society</organization>
<organization>Kyushu University</organization>
<address-part>3-1-1 Maidashi</address-part>
<city>Fukuoka</city>
<postal-code>812-8582</postal-code>
</affiliation>
<ce:e-address>makorin@med.kyushu-u.ac.jp</ce:e-address>
</correspondence>
<abstracts>
<abstract original="y">
<publishercopyright>Â© 2015 IMIA and IOS Press.</publishercopyright>
<ce:para>Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells. There is growing evidence that aminobisphosphonates like ibandronate show anticancer activity by an unknown mechanism. Biochemically, they prevent posttranslational isoprenylation of small GTPases, thus inhibiting their activity. In tumor cells, activated RAS-GTPase, the founding member of the gene family, down-regulates the expression of the pro-apoptotic gene FAS via epigenetic DNA-methylation by DNMT1. We compared ibandronate treatment in neoplastic human U-2 osteosarcoma and in mouse CCL-51 breast cancer cells as well as in the immortalized non-neoplastic MC3T3-E1 osteoblastic cells. Ibandronate attenuated cell proliferation in all cell lines tested. In the neoplastic cells we found up-regulation of caspases suggesting apoptosis. Further we found stimulation of FAS-expression as a result of epigenetic DNA demethylation that was due to down-regulation of DNMT1, which was rescued by re-isoprenylation by both geranylgeranyl-pyrophosphate and farnesylpyrophosphate. In contrast, ibandronate did not affect FAS and DNMT1 expression in MC3T3-E1 non-neoplastic cells. Data suggest that bisphosphonates via modulation of the activity of small-GTPases induce apoptosis in neoplastic cells by DNA-CpG-demethylation and stimulation of FAS-expression. In conclusion the shown epigenetic mechanism underlying the anti-neoplastic activity of farnesyl-transferase-inhibition, also explains the clinical success of other drugs, which target this pathway.</ce:para>
</abstract>
</abstracts>
<source type="k" country="nld">
<sourcetitle>Studies in Health Technology and Informatics</sourcetitle>
<sourcetitle-abbrev>Stud. Health Technol. Informatics</sourcetitle-abbrev>
<translated-sourcetitle xml:lang="eng">Studies in Health Technology and Informatics</translated-sourcetitle>
<issuetitle>MEDINFO 2015: eHealth-Enabled Health - Proceedings of the 15th World Congress on Health and Biomedical Informatics</issuetitle>
<issn type="electronic">18798365</issn>
<issn type="print">09269630</issn>
<isbn type="electronic" length="13" level="volume">9781614995630</isbn>
<volisspag>
<voliss volume="216"/>
<pagerange first="975"/>
</volisspag>
<publicationyear first="2015"/>
<publicationdate>
<year>2015</year>
</publicationdate>
<website>
<ce:e-address>http://www.iospress.nl/bookserie/studies-in-health-technology-and-informatics/</ce:e-address>
</website>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Georgiou A.</ce:indexed-name>
<ce:surname>Georgiou</ce:surname>
<ce:given-name>Andrew</ce:given-name>
</contributor>
</contributor-group>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>I.N.</ce:initials>
<ce:indexed-name>Sarkar I.N.</ce:indexed-name>
<ce:degrees>Dr.</ce:degrees>
<ce:surname>Sarkar</ce:surname>
<ce:given-name>Indra Neil</ce:given-name>
</contributor>
</contributor-group>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>P.M.</ce:initials>
<ce:indexed-name>de Azevedo Marques P.M.</ce:indexed-name>
<ce:surname>de Azevedo Marques</ce:surname>
<ce:given-name>Paulo Mazzoncini</ce:given-name>
</contributor>
</contributor-group>
<publisher>
<publishername>IOS Press</publishername>
<affiliation country="nld">
<address-part>Nieuwe Hemweg 6B</address-part>
<city>Amsterdam</city>
<postal-code>1013 BG</postal-code>
</affiliation>
</publisher>
<additional-srcinfo>
<conferenceinfo>
<confevent>
<confname>15th World Congress on Health and Biomedical Informatics, MEDINFO 2015</confname>
<confnumber>15</confnumber>
<conftheme>eHealth-Enabled Health</conftheme>
<confseriestitle>World Congress on Health and Biomedical Informatics</confseriestitle>
<conflocation country="bra">
<city>Sao Paulo</city>
</conflocation>
<confdate>
<startdate year="2015" month="08" day="19"/>
<enddate year="2015" month="08" day="23"/>
</confdate>
<confcode>116956</confcode>
<confsponsors complete="n">
<confsponsor></confsponsor>
</confsponsors>
</confevent>
</conferenceinfo>
</additional-srcinfo>
</source>
<enhancement>
<classificationgroup>
<classifications type="ASJC">
<classification>2204</classification>
<classification>2718</classification>
<classification>3605</classification>
</classifications>
</classificationgroup>
</enhancement>
</head>
<tail>
<bibliography refcount="1"/>
</tail>
</bibrecord>
</item>
</bibdataset>
